UDFAST-150 TABLETS
Ursodeoxycholic Acid 150mg
INDICATIONS
Dissolution of cholesterol-rich gallstones
Primary biliary cirrhosis
Prevention of gallstones in patients undergoing rapid wt loss
Exerts anticholestatic, antifibrotic and antiproliferative effects in primary cirrhosis
Improves bile acid transport and / or detoxification, cytoprotection and anti-apoptotic effects
Alters the composition of bile, increasing its concentrations and decreasing amounts of toxic bile acids
Early UDCA therapy is beneficial for slowing down the progression of liver pathology.
Zhonghua Gan Zang Bing Za Zhi. 2010 Oct;18(10):735-9.
Used in the treatment of cholestatic liver diseases, gallstone dissolution, and patients with hepatitis C virus unfection to ameliorate elevated alanine aminotransferase levels.
Hepatol Res. 2008;38(2):123-31. Epub 2007 Nov 23.